insulin human

FDA Drug Profile — MYXREDLIN

insulin human is listed in the FDA National Drug Code directory with 7 NDC codes, marketed under brand name including MYXREDLIN. Available dosage forms: powder, injection, solution.

Drug details

Generic Name
insulin human
Brand Names
MYXREDLIN
Application Number
BLA208157
Sponsor
Virtu Pharmako (Zhejiang) Co., Ltd.
NDC Codes
7
Dosage Forms
POWDER, INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients
INSULIN HUMAN

Indications and Usage

1 INDICATIONS AND USAGE HUMULIN R U-500 is a concentrated human insulin indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus requiring more than 200 units of insulin per day. HUMULIN ® R U-500 is a concentrated human insulin indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus requiring more than 200 units of insulin per day. ( 1 ) Limitation of Use: The safety and efficacy of HUMULIN R U-500 used in combination with other insulins has not been determined. The safety and efficacy of HUMULIN R U-500 delivered by continuous subcutaneous infusion has not been determined. ( 1.1 ) 1.1 Limitation of Use The safety and efficacy of HUMULIN R U-500 used in combination with other insulins has not been determined. The safety and efficacy of HUMULIN R U-500 delivered by continuous subcutaneous infusion has not been determined.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.